Vanguard Health Care ETF (VHT)

Add to Watchlists
Create an Alert
170.64 -0.71  -0.41% NYSE Arca Oct 18, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 170.67
Discount or Premium to NAV -0.01%
Turnover Ratio 6.00%
1 Year Fund Level Flows 480.04M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 0.06% 0.14% -1.42% 24
3M -1.63% -1.61% -3.14% 31
6M 6.78% 6.79% 3.58% 37
YTD 8.04% 8.12% 9.13% 55
1Y 0.09% 0.16% -4.33% 29
3Y 11.57% 11.56% 10.22% 33
5Y 10.44% 10.44% 8.28% 22
10Y 14.49% 14.50% 13.90% 42
15Y 10.71% 10.71% 10.80% 50
20Y -- -- 10.33% --
As of Oct. 18, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.81% 0.81% 0.00%
Stock 99.19% 99.19% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2019

Region Exposure

Americas 99.69%
North America 99.68%
Latin America 0.01%
Greater Europe 0.30%
United Kingdom 0.27%
Europe Developed 0.03%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.01%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.01%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Sept. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.08%
Communication Services 0.00%
Consumer Cyclical 0.01%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.03%
Healthcare 97.99%
Industrials 0.09%
Real Estate 0.00%
Technology 1.80%
Utilities 0.00%
As of Sept. 30, 2019

Stock Market Capitalization

Giant 45.40%
Large 33.20%
Medium 14.83%
Small 5.81%
Micro 0.75%
As of Sept. 30, 2019

Stock Style Exposure

Large Cap Value 31.38%
Large Cap Blend 25.42%
Large Cap Growth 22.29%
Mid Cap Value 2.22%
Mid Cap Blend 2.71%
Mid Cap Growth 9.89%
Small Cap Value 0.55%
Small Cap Blend 1.27%
Small Cap Growth 4.28%
As of Sept. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 8.63% 127.70 -6.22%
MRK Merck & Co Inc 5.44% 84.68 +1.05%
UNH UnitedHealth Group Inc 5.19% 245.34 +0.69%
PFE Pfizer Inc 4.93% 36.46 +0.00%
ABT Abbott Laboratories 3.71% 82.79 +0.50%
MDT Medtronic PLC 3.66% 108.12 -0.36%
AMGN Amgen Inc 2.96% 202.72 -0.41%
TMO Thermo Fisher Scientific Inc 2.93% 281.42 -0.06%
ABBV AbbVie Inc 2.81% 76.46 +1.76%
LLY Eli Lilly and Co 2.45% 108.64 +0.17%
As of Sept. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Vanguard
Reports
One Page Report Download

Manager Info

Name Tenure
Michelle Louie 1.58 yrs
Walter Nejman 3.52 yrs

Net Fund Flows

1M -72.93M
3M -224.36M
6M -399.20M
YTD 63.37M
1Y 480.04M
3Y 1.859B
5Y 3.894B
10Y 5.774B
As of Sept. 30, 2019

Risk Info

Beta (5Y) 0.9342
Max Drawdown (All) 39.01%
Historical Sharpe Ratio (10Y) 1.148
Historical Sortino (All) 0.7235
30-Day Rolling Volatility 13.79%
Daily Value at Risk (VaR) 1% (All) 2.90%
Monthly Value at Risk (VaR) 1% (All) 12.56%

Fundamentals

Dividend Yield TTM (10-18-19) 2.07%
30-Day SEC Yield (10-17-19) 1.49%
7-Day SEC Yield --
Weighted Average PE Ratio 22.32
Weighted Average Price to Sales Ratio 1.765
Weighted Average Price to Book Ratio 3.884
Weighted Median ROE 21.55%
Weighted Median ROA 6.99%
Forecasted Dividend Yield 1.59%
Forecasted PE Ratio 15.91
Forecasted Price to Sales Ratio 1.729
Forecasted Price to Book Ratio 3.729
Number of Holdings 390
As of Sept. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.02%
Forecasted Book Value Growth 3.74%
Forecasted Cash Flow Growth 4.34%
Forecasted Earnings Growth 18.68%
Forecasted Revenue Growth 8.55%
As of Sept. 30, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 1/26/2004
Termination Date
Last Annual Report Date 8/31/2018
Last Prospectus Date 12/3/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.